Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II

Por: Pessoa, Joao, Valenti, Maria Teresa, Bellance, Nadege, Chiarella, Paula, Abebe, Tamrat, Gerratana, Lorenzo, Perez-Plasencia, Carlos, Kzhyshkowska, Julia

---

Publicada: 1 ene 2023

---

---

Filiaciones:
Pessoa, Joao:
 CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal

 CIBB - Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal

Valenti, Maria Teresa:
 Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy

Bellance, Nadege:
 INSERM U1211, Rare Diseases: Genetic and Metabolism, University of Bordeaux, Bordeaux, France

Chiarella, Paula:
 Department of Experimental Oncology, Instituto de Medicina Experimental, Academia Nacional de Medicina de Buenos Aires, Ciudad Autónima de Buenos Aires, Argentina

Abebe, Tamrat:
 Department of Microbiology, Immunology and Parasitology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia

Gerratana, Lorenzo:
 Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy

Perez-Plasencia, Carlos:
 Laboratorio de Genómica, Instituto Nacional de Cancerología, Tlalpan, Mexico

 Laboratorio de Genómica Funcional, Unidad de Biomedicina, FES-IZTACALA, Universidad Nacional Autónoma de México, Tlalnepantla, Mexico

Kzhyshkowska, Julia:
 Institute of Transfusion Medicine and Immunology, Mannheim Institute for Innate Immunosciences (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

 German Red Cross Blood Service Baden-Württemberg – Hessen, Mannheim, Germany

 Laboratory for Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russian Federation

 Laboratory for Gene Technology, Siberian State Medical University, Tomsk, Russian Federation